Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
Clinical trial NCT00022971 · TERMINATED
Trial details
- NCT number
- NCT00022971
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-15
- Primary completion
- 2010-01-22
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.